Scientists have successfully revived 160-million-year-old proteins in an effort to combat the growing global health threat of drug-resistant bacteria.
By resurrecting ancient biological molecules preserved from millions of years ago, researchers are exploring innovative ways to target and neutralize modern bacterial pathogens that have developed resistance to conventional antibiotics. This novel approach leverages evolutionary biology to discover alternative therapeutic agents.
The successful revival of these ancient proteins marks a significant step forward in pharmaceutical research, offering a promising new avenue for the development of advanced treatments against resistant infections.
In-depth summary · AI, neutral